PRELIMINARY PROGRAM DESCRIPTION

This full-day conference will provide essential updates on the MDR/IVDR legal framework, Eudamed, and transition periods, delivered by experts from the FAMHP. Dive into pre-marketing strategies, including national regulatory advice, clinical investigations, and the impact of IVDR on clinical trials. Post-marketing topics such as materiovigilance, shortages, and hospitals' obligations under MDR/IVDR will also be addressed. Finally, explore the regulatory challenges and opportunities for AI and connected devices, with insights into the interplay of key legislations like the AI Act, GDPR, and MDR/IVDR. Don’t miss this opportunity to stay ahead in the medtech sector!

Detailed program will follow, but you can already register!